POPULATION PHARMACOKINETICS OF MYCOPHENOLIC ACID: A COMPARISON BETWEEN ENTERIC-COATED MYCOPHENOLATE SODIUM AND MYCOPHENOLATE MOFETIL IN RENAL TRANSPLANT RECIPIENTS: 2607

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Transplantation

• Publication date

  2010-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/00007890-201007272-01180
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Pharmacokinetics and abbreviated AUC model of enteric-coated mycophenolate sodium in early kidney transplant recipients receiving tacrolimus

  2025influential citation
• Published population pharmacokinetic models of mycophenolate sodium: a systematic review and external evaluation in a Chinese sample of renal transplant recipients

  2025cites this paper
• Therapeutic drug monitoring of mycophenolic acid and clinical outcomes of lupus nephritis: a systematic review and meta-analysis

  2024cites this paper
• Safety of the reduced fixed dose of mycophenolate mofetil confirmed via therapeutic drug monitoring in de novo kidney transplant recipients

  2024cites this paper
• Population pharmacokinetics of mycophenolic acid and dose optimisation in adult Chinese kidney transplant recipients

  2023influential citation
• Population pharmacokinetic and dose optimization of mycophenolic acid in children with anti-neutrophilic cytoplasmic antibody-associated nephritis

  2022influential citation
• Estimation of Mycophenolic Acid Exposure in Chinese Renal Transplant Patients by a Joint Deep Learning Model

  2022cites this paper
• [Pharmacokinetic study of mycophenolic acid in pediatric kidney transplantation].

  2022cites this paper
• Recent lessons learned from population pharmacokinetic studies of mycophenolic acid: physiological, genomic, and drug interactions leading to the prediction of drug effects

  2021cites this paper
• Early prognostic performance of miR155-5p monitoring for the risk of rejection: Logistic regression with a population pharmacokinetic approach in adult kidney transplant patients

  2021cites this paper
• Population pharmacokinetics of mycophenolic acid in pediatric patients with juvenile dermatomyositis and optimization of limited sampling strategy

  2020influential citation
• Population pharmacokinetics of mycophenolic acid in paediatric patients

  2020cites this paper
• Mycophenolic Acid Trough Concentration and Dose Are Associated with Hematologic Abnormalities but Not Rejection in Kidney Transplant Recipients

  2020cites this paper
• Inosine 5'-Monophosphate Dehydrogenase Activity for the Longitudinal Monitoring of Mycophenolic Acid Treatment in Kidney Allograft Recipients.

  2020cites this paper
• Impacto del polimorfismo MRP2 24ct en el trasplante renal en tratamiento con ácido micofenólico: farmacocinética y repercusión clínica

  2019cites this paper
• Effect of Protein Binding on Exposure of Unbound and Total Mycophenolic Acid: A Population Pharmacokinetic Analysis in Chinese Adult Kidney Transplant Recipients

  2019influential citation
• Monitoring of Mycophenolic Acid Trough Concentration in Kidney Transplant under Cyclosporine Is Beneficial in Reducing Acute Rejection within 1 Year

  2018cites this paper
• Clinical Implication of Mycophenolic Acid Trough Concentration Monitoring in Kidney Transplant Patients on a Tacrolimus Triple Maintenance Regimen: A Single-Center Experience

  2017cites this paper
• The Impact of Total Gastrectomy on Pharmacokinetics in Kidney Transplant Immunosuppressive Drug Regimes: A Case Study

  2017cites this paper
• Pharmacokinetics, Pharmacodynamics, and Pharmacogenomics of Immunosuppressants in Allogeneic Hematopoietic Cell Transplantation: Part II

  2016cites this paper
• Pharmacokinetic Analysis of Mycophenolate Mofetil and Enteric-Coated Mycophenolate Sodium in Calcineurin Inhibitor–Free Renal Transplant Recipients

  2016cites this paper
• Therapeutic drug monitoring of enteric-coated mycophenolate sodium by limited sampling strategies is associated with a high rate of failure

  2016cites this paper
• Estimation of Mycophenolic Acid Area Under the Curve With Limited-Sampling Strategy in Chinese Renal Transplant Recipients Receiving Enteric-Coated Mycophenolate Sodium

  2016cites this paper
• Pharmacokinetics of mycophenolate sodium co-administered with tacrolimus in the first year after renal transplantation

  2015cites this paper
• Effect of Cyclosporine on Steady-State Pharmacokinetics of MPA in Renal Transplant Recipients Is Not Affected by the MPA Formulation: Analysis Based on Therapeutic Drug Monitoring Data

  2014cites this paper
• How Accurate and Precise Are Limited Sampling Strategies in Estimating Exposure to Mycophenolic Acid in People with Autoimmune Disease?

  2014cites this paper
• 5′‐AMP impacts lymphocyte recirculation through activation of A2B receptors

  2013cites this paper
• Identification of the Molecular Mechanisms underlying the Gastrointestinal Toxicity of the Immunosuppressants Mycophenolate Mofetil and Enteric-coated Mycophenolate Sodium using a Proteo-Metabolomic Approach

  2013cites this paper
• Development and Validation of Limited Sampling Strategies for the Estimation of Mycophenolic Acid Area Under the Curve in Adult Kidney and Liver Transplant Recipients Receiving Concomitant Enteric-Coated Mycophenolate Sodium and Tacrolimus

  2013cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Mycophenolate in Patients with Autoimmune Disease

  2013cites this paper
• Population Pharmacokinetics and Dose Optimization of Mycophenolic Acid in HCT Recipients Receiving Oral Mycophenolate Mofetil

  2013cites this paper
• Development of population PK model with enterohepatic circulation for mycophenolic acid in patients with childhood-onset systemic lupus erythematosus.

  2012cites this paper
• The influence of UGT polymorphisms as biomarkers in solid organ transplantation.

  2012cites this paper
• Steroid avoidance with early intensified dosing of enteric-coated mycophenolate sodium: a randomized multicentre trial in kidney transplant recipients.

  2012cites this paper
• Pharmacokinetics and pharmacodynamics of mycophenolate sodium (EC‐MPS) co‐administered with cyclosporine in the early‐phase post‐kidney transplantation

  2012cites this paper
• Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoring.

  2011cites this paper
• Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.

  2011influential citation
• Population pharmacokinetics of mycophenolic acid in pediatric renal transplant patients using parametric and nonparametric approaches.

  2011cites this paper
• A Possible Simplification for the Estimation of Area Under the Curve (AUC0–12) of Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients Receiving Tacrolimus

  2011cites this paper
• Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome.

  2011cites this paper
• Enteric-coated mycophenolate sodium

  2010cites this paper
• Population Pharmacokinetic Analysis of Mycophenolic Acid Coadministered With Either Tasocitinib (CP-690,550) or Tacrolimus in Adult Renal Allograft Recipients

  2010influential citation
• Consensus report on therapeutic drug monitoring of mycophenolic acid in solid organ transplantation.

  2010influential citation
• Therapeutic drug monitoring of mycophenolate mofetil and enteric-coated mycophenolate sodium in patients with systemic lupus erythematosus

  2010cites this paper
• Limited Sampling Strategies Drawn Within 3 Hours Postdose Poorly Predict Mycophenolic Acid Area-Under-the-Curve After Enteric-Coated Mycophenolate Sodium

  2009cites this paper
• New Insights Into the Pharmacokinetics and Pharmacodynamics of the Calcineurin Inhibitors and Mycophenolic Acid: Possible Consequences for Therapeutic Drug Monitoring in Solid Organ Transplantation

  2009cites this paper
• Mycophenolate Blood Level Monitoring: Recent Progress

  2009cites this paper